Holen Sie sich die Stockscreener-App
2.83
1.43%
0.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ACHV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$2.79
Offen:
$2.79
24-Stunden-Volumen:
1.42M
Relative Volume:
1.17
Marktkapitalisierung:
$144.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-32.94M
KGV:
-2.5495
EPS:
-1.11
Netto-Cashflow:
$-24.95M
1W Leistung:
-5.03%
1M Leistung:
+8.02%
6M Leistung:
-1.74%
1J Leistung:
-31.97%
1-Tages-Spanne:
$2.68
$2.87
1-Wochen-Bereich:
$2.68
$3.1399
52-Wochen-Spanne:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Firmenname
Achieve Life Sciences Inc
Sektor
Branche
Telefon
425-686-1500
Adresse
22722 29TH DR. SE, SEATTLE, BC
Vergleichen Sie ACHV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.83 | 142.58M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-21 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-11-14 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-09-27 | Eingeleitet | Raymond James | Strong Buy |
| 2023-05-10 | Bestätigt | Maxim Group | Buy |
| 2021-06-23 | Eingeleitet | Oppenheimer | Outperform |
Achieve Life Sciences Inc Aktie (ACHV) Neueste Nachrichten
Volume spikes in Achieve Life Sciences Inc. stock – what they meanWeekly Market Outlook & Weekly High Return Stock Forecasts - Newser
Analyzing Achieve Life Sciences Inc. with risk reward ratio chartsJuly 2025 Trade Ideas & Stock Timing and Entry Methods - Newser
Exit strategy if you’re trapped in Achieve Life Sciences Inc.July 2025 Summary & Low Drawdown Trading Strategies - Newser
Is Achieve Life Sciences Inc. forming a breakout pattern2025 Key Highlights & Verified Short-Term Trading Plans - خودرو بانک
Achieve Life Sciences, Inc. $ACHV Shares Purchased by Nantahala Capital Management LLC - MarketBeat
How institutional ownership impacts Achieve Life Sciences Inc. stock2025 Bull vs Bear & Growth-Oriented Investment Plans - Newser
Can trapped investors hope for a rebound in Achieve Life Sciences Inc.Market Growth Summary & Stock Portfolio Risk Control - Newser
News impact scoring models applied to Achieve Life Sciences Inc.IPO Watch & Verified Entry Point Detection - Newser
Comparing Achieve Life Sciences Inc. in custom built stock radars2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Will Achieve Life Sciences Inc. see short term momentum - Newser
Is Achieve Life Sciences Inc. showing signs of accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Should you wait for a breakout in Achieve Life Sciences Inc.July 2025 Analyst Calls & Real-Time Market Sentiment Reports - Newser
Chart based analysis of Achieve Life Sciences Inc. trendsBull Run & Risk Managed Trade Strategies - Newser
Using portfolio simulators with Achieve Life Sciences Inc. included2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Smart tools for monitoring Achieve Life Sciences Inc.’s price actionEarnings Risk Summary & Community Verified Watchlist Alerts - Newser
Achieve Life Sciences shares fall 1.75% premarket after FDA acceptance of cytisinicline NDA for smoking cessation. - AInvest
What is the target price for Achieve Life Sciences Inc. stockBuy Signal & Weekly High Conviction Ideas - خودرو بانک
Order flow analysis tools used on Achieve Life Sciences Inc.Weekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Using flow based indicators on Achieve Life Sciences Inc.July 2025 Sentiment & Low Drawdown Momentum Trade Ideas - Newser
Achieve Life Sciences shares rise 1.36% after-hours after FDA acceptance of cytisinicline NDA for smoking cessation. - AInvest
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation - MarketScreener
FDA accepts Achieve Life Sciences’ NDA for smoking cessation drug - Investing.com
Achieve Life Sciences' nicotine dependence treatment under FDA review - Seeking Alpha
Achieve Life Sciences Says FDA Accepts Marketing Application for Smoking Cessation Drug - MarketScreener
Achieve Life Sciences Announces FDA Acceptance of - GlobeNewswire
First New Smoking Cessation Drug in Two Decades: FDA to Review Achieve's Cytisinicline Treatment - Stock Titan
Real time breakdown of Achieve Life Sciences Inc. stock performance2025 Risk Factors & Consistent Growth Equity Picks - Newser
Should you avoid Achieve Life Sciences Inc. stock right nowJuly 2025 Macro Moves & Scalable Portfolio Growth Methods - خودرو بانک
Published on: 2025-09-03 03:38:25 - Newser
Can Achieve Life Sciences Inc. outperform in the next rallyJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - خودرو بانک
Measuring Achieve Life Sciences Inc.’s beta against major indicesJuly 2025 Snapshot & Daily Risk Controlled Trade Plans - Newser
Technical analysis overview for Achieve Life Sciences Inc. stockIPO Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Achieve Life Sciences shares rise 2.05% after-hours as CEO Rick Stewart participates in upcoming conferences. - AInvest
Is Achieve Life Sciences Inc. benefiting from interest rate changesWeekly Profit Recap & Expert Curated Trade Setups - خودرو بانک
Is Achieve Life Sciences Inc. a cyclical or defensive stockTake Profit & Real-Time Buy Signal Notifications - khodrobank.com
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences - GlobeNewswire
Achieve Life Sciences CEO to Present at Two Upcoming Conferences. - AInvest
Smoking Cessation Drug Developer Achieve Life Sciences Featured at Two Major Investment Conferences - Stock Titan
Why Achieve Life Sciences Inc. stock attracts strong analyst attentionMarket Risk Summary & Daily Market Momentum Tracking - Newser
What makes Achieve Life Sciences Inc. stock attractive to long term investorsTrade Risk Report & Risk Adjusted Buy and Sell Alerts - Newser
Is Achieve Life Sciences Inc. in accumulation or distribution phaseJuly 2025 Analyst Calls & Fast Gain Swing Alerts - خودرو بانک
Finanzdaten der Achieve Life Sciences Inc-Aktie (ACHV)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):